• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将G蛋白偶联受体相关通路作为新兴分子疗法的靶点。

Targeting G protein coupled receptor-related pathways as emerging molecular therapies.

作者信息

Ghanemi Abdelaziz

机构信息

Department of Pharmacology, China Pharmaceutical University, Nanjing 210009, China.

出版信息

Saudi Pharm J. 2015 Apr;23(2):115-29. doi: 10.1016/j.jsps.2013.07.007. Epub 2013 Aug 13.

DOI:10.1016/j.jsps.2013.07.007
PMID:25972730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4420995/
Abstract

G protein coupled receptors (GPCRs) represent the most important targets in modern pharmacology because of the different functions they mediate, especially within brain and peripheral nervous system, and also because of their functional and stereochemical properties. In this paper, we illustrate, via a variety of examples, novel advances about the GPCR-related molecules that have been shown to play diverse roles in GPCR pathways and in pathophysiological phenomena. We have exemplified how those GPCRs' pathways are, or might constitute, potential targets for different drugs either to stimulate, modify, regulate or inhibit the cellular mechanisms that are hypothesized to govern some pathologic, physiologic, biologic and cellular or molecular aspects both in vivo and in vitro. Therefore, influencing such pathways will, undoubtedly, lead to different therapeutical applications based on the related pharmacological implications. Furthermore, such new properties can be applied in different fields. In addition to offering fruitful directions for future researches, we hope the reviewed data, together with the elements found within the cited references, will inspire clinicians and researchers devoted to the studies on GPCR's properties.

摘要

G蛋白偶联受体(GPCRs)是现代药理学中最重要的靶点,这是因为它们介导多种不同功能,尤其是在脑和外周神经系统中,还因为它们具有功能和立体化学特性。在本文中,我们通过各种实例阐述了与GPCR相关分子的新进展,这些分子已被证明在GPCR途径和病理生理现象中发挥着多种作用。我们举例说明了这些GPCR途径如何或可能构成不同药物的潜在靶点,这些药物可刺激、改变、调节或抑制细胞机制,这些细胞机制被认为在体内和体外控制着某些病理、生理、生物学以及细胞或分子方面。因此,基于相关药理学意义,影响这些途径无疑将导致不同的治疗应用。此外,这些新特性可应用于不同领域。除了为未来研究提供富有成效的方向外,我们希望所综述的数据以及参考文献中发现的内容能够激发致力于GPCR特性研究的临床医生和研究人员。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a9f/4420995/f4d031edc0de/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a9f/4420995/4e43a61935ef/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a9f/4420995/f4d031edc0de/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a9f/4420995/4e43a61935ef/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a9f/4420995/f4d031edc0de/gr1.jpg

相似文献

1
Targeting G protein coupled receptor-related pathways as emerging molecular therapies.将G蛋白偶联受体相关通路作为新兴分子疗法的靶点。
Saudi Pharm J. 2015 Apr;23(2):115-29. doi: 10.1016/j.jsps.2013.07.007. Epub 2013 Aug 13.
2
Elements toward novel therapeutic targeting of the adrenergic system.肾上腺素能系统新型治疗靶点的相关要素。
Neuropeptides. 2015 Feb;49:25-35. doi: 10.1016/j.npep.2014.11.003. Epub 2014 Nov 24.
3
Small molecules targeting heterotrimeric G proteins.靶向异三聚体 G 蛋白的小分子。
Eur J Pharmacol. 2018 May 5;826:169-178. doi: 10.1016/j.ejphar.2018.03.003. Epub 2018 Mar 6.
4
Targeting platelet G-protein coupled receptors (GPCRs): looking beyond conventional GPCR antagonism.靶向血小板 G 蛋白偶联受体(GPCRs):超越传统的 GPCR 拮抗作用。
Curr Vasc Pharmacol. 2010 Mar;8(2):140-54. doi: 10.2174/157016110790886938.
5
G protein-coupled receptors and their signaling pathways: classical therapeutical targets susceptible to novel therapeutic concepts.G蛋白偶联受体及其信号通路:易受新型治疗理念影响的经典治疗靶点。
Curr Pharm Des. 2004;10(16):1937-58. doi: 10.2174/1381612043384367.
6
G-protein-coupled receptors: an update.G蛋白偶联受体:最新进展
Acta Physiol (Oxf). 2007 May;190(1):3-7. doi: 10.1111/j.1365-201X.2007.01689.x.
7
Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential.G 蛋白偶联受体(GPCR)的偏向信号传导:GPCR/转导器选择性和治疗潜力的分子决定因素。
Pharmacol Ther. 2019 Aug;200:148-178. doi: 10.1016/j.pharmthera.2019.05.006. Epub 2019 May 8.
8
[Selective signaling pathway via feeding-related ciliary GPCR, melanin-concentrating hormone receptor 1].[通过与进食相关的纤毛G蛋白偶联受体(黑素浓缩激素受体1)的选择性信号通路]
Nihon Yakurigaku Zasshi. 2019;154(4):179-185. doi: 10.1254/fpj.154.179.
9
Desensitization of G protein-coupled receptors and neuronal functions.G蛋白偶联受体的脱敏作用与神经元功能
Annu Rev Neurosci. 2004;27:107-44. doi: 10.1146/annurev.neuro.27.070203.144206.
10
Targeting the PAC1 Receptor for Neurological and Metabolic Disorders.针对神经和代谢紊乱的 PAC1 受体。
Curr Top Med Chem. 2019;19(16):1399-1417. doi: 10.2174/1568026619666190709092647.

引用本文的文献

1
Diet Impact on Obesity beyond Calories and Trefoil Factor Family 2 (TFF2) as an Illustration: Metabolic Implications and Potential Applications.饮食对肥胖的影响超出了卡路里和三叶因子家族 2(TFF2)的影响:代谢影响和潜在应用。
Biomolecules. 2021 Dec 4;11(12):1830. doi: 10.3390/biom11121830.
2
CXCL16/CXCR6 Axis in Adipocytes Differentiated from Human Adipose Derived Mesenchymal Stem Cells Regulates Macrophage Polarization.脂肪细胞来源的间充质干细胞分化而来的脂肪细胞中的 CXCL16/CXCR6 轴调节巨噬细胞极化。
Cells. 2021 Dec 3;10(12):3410. doi: 10.3390/cells10123410.
3
Roles of Endothelial Motilin Receptor and Its Signal Transduction Pathway in Motilin-Induced Left Gastric Artery Relaxation in Dogs.

本文引用的文献

1
Psychiatric neural networks and neuropharmacology: Selected advances and novel implications.精神神经科学网络与神经药理学:精选进展及新启示。
Saudi Pharm J. 2014 Apr;22(2):95-100. doi: 10.1016/j.jsps.2013.01.008. Epub 2013 Feb 10.
2
Biological properties and perspective applications of "Bio-neuter" chemicals?“生物绝育”化学品的生物学特性及潜在应用?
Saudi Pharm J. 2014 Jan;22(1):1-2. doi: 10.1016/j.jsps.2013.01.006.
3
Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy.
内皮细胞胃动素受体及其信号转导通路在胃动素诱导犬胃左动脉舒张中的作用
Front Physiol. 2021 Oct 28;12:770430. doi: 10.3389/fphys.2021.770430. eCollection 2021.
4
Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function.关于 G 蛋白偶联雌激素受体 GPER 功能调节的治疗观点。
Front Endocrinol (Lausanne). 2020 Nov 23;11:591217. doi: 10.3389/fendo.2020.591217. eCollection 2020.
5
ONC201 and imipridones: Anti-cancer compounds with clinical efficacy.ONC201 和伊马替尼:具有临床疗效的抗癌化合物。
Neoplasia. 2020 Dec;22(12):725-744. doi: 10.1016/j.neo.2020.09.005. Epub 2020 Oct 23.
6
Regulation of CXCR6 Expression on Adipocytes and Osteoblasts Differentiated from Human Adipose Tissue-Derived Mesenchymal Stem Cells.人脂肪组织来源间充质干细胞分化的脂肪细胞和成骨细胞上CXCR6表达的调控
Stem Cells Int. 2020 Aug 19;2020:8870133. doi: 10.1155/2020/8870133. eCollection 2020.
7
The signaling proteins GPR158 and RGS7 modulate excitability of L2/3 pyramidal neurons and control A-type potassium channel in the prelimbic cortex.信号蛋白 GPR158 和 RGS7 调节前额皮质 L2/3 锥体神经元的兴奋性,并控制 A 型钾通道。
J Biol Chem. 2019 Aug 30;294(35):13145-13157. doi: 10.1074/jbc.RA119.007533. Epub 2019 Jul 16.
8
Dopaminergic gene methylation is associated with cognitive performance in a childhood monozygotic twin study.多巴胺能基因甲基化与儿童同卵双胞胎研究中的认知表现相关。
Epigenetics. 2019 Mar;14(3):310-323. doi: 10.1080/15592294.2019.1583032. Epub 2019 Mar 16.
9
Importance of GPCR-Mediated Microglial Activation in Alzheimer's Disease.G蛋白偶联受体介导的小胶质细胞激活在阿尔茨海默病中的重要性。
Front Cell Neurosci. 2018 Aug 21;12:258. doi: 10.3389/fncel.2018.00258. eCollection 2018.
10
Presymptomatic change in microRNAs modulates Tau pathology.微 RNA 在前症期变化调节 Tau 病理。
Sci Rep. 2018 Jun 18;8(1):9251. doi: 10.1038/s41598-018-27527-6.
发现β-arrestin 偏向性多巴胺 D2 配体,用于探测对抗精神病药物疗效至关重要的信号转导途径。
Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18488-93. doi: 10.1073/pnas.1104807108. Epub 2011 Oct 24.
4
Multiple signal transduction pathways alterations during nerve agent toxicity.多种信号转导通路在神经毒剂毒性中的改变。
Toxicol Lett. 2012 Jan 5;208(1):16-22. doi: 10.1016/j.toxlet.2011.09.022. Epub 2011 Oct 4.
5
Age-related β-adrenergic receptor-mediated vasorelaxation is changed by altering G protein receptor kinase 2 expression.年龄相关的β-肾上腺素能受体介导的血管舒张功能变化可通过改变 G 蛋白受体激酶 2 的表达来实现。
Vascul Pharmacol. 2011 Nov-Dec;55(5-6):178-88. doi: 10.1016/j.vph.2011.09.001. Epub 2011 Sep 17.
6
Anxiolytic effects of 5-HT₁A receptors and anxiogenic effects of 5-HT₂C receptors in the amygdala of mice.5-HT₁A 受体的抗焦虑作用和 5-HT₂C 受体的焦虑作用在小鼠杏仁核中的表现。
Neuropharmacology. 2012 Jan;62(1):474-84. doi: 10.1016/j.neuropharm.2011.09.002. Epub 2011 Sep 14.
7
G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.G 蛋白偶联受体激酶:不只是激酶,也不仅作用于 GPCR。
Pharmacol Ther. 2012 Jan;133(1):40-69. doi: 10.1016/j.pharmthera.2011.08.001. Epub 2011 Aug 26.
8
Artificial membrane-like environments for in vitro studies of purified G-protein coupled receptors.用于纯化G蛋白偶联受体体外研究的人工膜样环境。
Biochim Biophys Acta. 2012 Feb;1818(2):225-33. doi: 10.1016/j.bbamem.2011.07.047. Epub 2011 Aug 9.
9
G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei--serpentine gateways to neuroendocrine homeostasis.下丘脑室旁核和视上核中的 G 蛋白偶联受体——神经内分泌稳态的蜿蜒门户。
Front Neuroendocrinol. 2012 Jan;33(1):45-66. doi: 10.1016/j.yfrne.2011.07.002. Epub 2011 Jul 23.
10
Direct-reversible binding of small molecules to G protein βγ subunits.小分子与G蛋白βγ亚基的直接可逆结合。
Biochim Biophys Acta. 2011 Sep;1814(9):1210-8. doi: 10.1016/j.bbapap.2011.05.010. Epub 2011 May 18.